Haley Ellis

6PUBLICATIONS
99CO-AUTHORS
Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 29, 2025
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Jinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis

|Mar 04, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.

Eranga R Balasooriya, Qibiao Wu, Haley Ellis

|Nov 02, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.

Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin

|Oct 16, 2023
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.

Qibiao Wu, Haley Ellis, Giulia Siravegna

|Sep 11, 2023
KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential.

Hiroyuki Kato, Haley Ellis, Nabeel Bardeesy

Pageof 1